Q1 2021 · —
Revenue—
Net Income-$27.00M-$27.00M no prior Q1 2020 on fileno prior Q4 2020 on file
EPS Diluted-$64.41-$64.41 no prior Q1 2020 on fileno prior Q4 2020 on file
Operating Income-$3,793,000—
Operating Cash Flow-$2,370,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q1 2020 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acumen Pharmaceuticals, Inc. · CIK 1576885 · Engraved from SEC EDGAR